Base de dados : HANSEN
Pesquisa : NEOPLASIAS CUTANEAS/GENET [Descritor de assunto]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 HANSEN  
              next record last record
seleciona
para imprimir
Id:24490
Autor:Wilkins K; Turner R; Dolev JC; LeBoit PE; Berger TG; Maurer TA
Título:Cutaneous malignancy and human immunodeficiency virus disease
Cutaneous malignancy and human immunodeficiency virus disease-v.54
Fonte:s.l; s.n; 2006. 17 p. tab.
Resumo:Certain skin cancers occur with increased frequency or altered course in patients infected with HIV. Malignant melanoma and squamous cell carcinoma are examples of cutaneous malignancies that have a more aggressive course in patients with HIV. Others, such as basal cell carcinoma, appear more frequently in this population but do not appear to be more aggressive. The incidence of HIV-associated Kapsosi's sarcoma has markedly decreased since the advent of HIV antiretroviral therapy. Our understanding of the pathogenesis of this malignancy and its unique management issues are fully reviewed. Cutaneous T-cell lymphoma (CTCL) is rare in this population. Other types of cutaneous lymphoma and HIV-associated pseudo-CTCL are discussed. This article addresses prevention, treatment, and follow-up strategies for this at-risk population. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the unique epidemiology, clinical course, and management of cutaneous malignancy in patients infected with HIV...(AU.
Descritores:NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/microbiol
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/virol
LINFOMA/genet
LINFOMA/fisiopatol
LINFOMA/virol
MELANOMA/fisiopatol
MELANOMA/virol
CARCINOMA/fisiopatol
 CARCINOMA/virol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00318/cme


  2 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24487
Autor:Wright TI; Spencer JM; Flowers FP
Título:Chemoprevention of nonmelanoma skin cancer
Chemoprevention of nonmelanoma skin cancer-v.54
Fonte:s.l; s.n; 2006. 13 p. ilus, tab.
Resumo:Skin cancer is the most common cancer in human beings. The increased incidence of skin cancer has brought much attention to the process by which these tumors develop and how they can be prevented. Efforts have been made to educate the public about the importance of protecting skin from excessive ultraviolet light. Despite this work, the incidence of skin cancer continues to increase. Available compounds may be useful in the chemoprevention of skin cancer. Chemoprevention is defined as oral or topical use of dietary or pharmacologic agents to inhibit or reverse the development of cancer. Potential agents included are the retinoids; difluoromethylornithine; T4 endonuclease V; polyphenolic antioxidants, such as (-)-epigallocatechin gallate, found in green tea and grape seed extract; silymarin; isoflavone genestein; nonsteroidal anti-inflammatory drugs; curcumin; lycopene; vitamin E; beta-carotene; and selenium. Many of these agents are available over the counter as topical or oral preparations. LEARNING OBJECTIVE: At the conclusion of this activity, participants should be familiar with the chemopreventive agents and their efficacy, as well as any significant side effects associated with them...(AU).
Descritores:NEOPLASIAS CUTÂNEAS/quimioter
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/prev
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/terap
SILIMARINA/sint quim
 SILIMARINA/farmacol
 SILIMARINA/uso terap
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00321/cme


  3 / 4 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:24485
Autor:Izikson L; English JC; Zirwas MJ
Título:The flushing patient: differential diagnosis, workup, and treatment
The flushing patient: differential diagnosis, workup, and treatment-v.55
Fonte:s.l; s.n; 2006. 15 p. ilus.
Resumo:Cutaneous flushing-a common presenting complaint to dermatologists, allergists, internists, and family practitioners-results from changes in cutaneous blood flow triggered by multiple conditions. Most cases are caused by very common, benign diseases, such as rosacea or climacterum, that are readily apparent after a thorough taking of history and physical examination. However, in some cases, accurate diagnosis requires further laboratory, radiologic, or histopathologic studies to differentiate several important clinicopathologic entities. In particular, the serious diagnoses of carcinoid syndrome, pheochromocytoma, mastocytosis, and anaphylaxis need to be excluded by laboratory studies. If this work-up is unrevealing, rare causes, such as medullary carcinoma of the thyroid, pancreatic cell tumor, renal carcinoma, and others, should be considered. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the mechanisms of flushing, its clinical differential diagnosis, the approach to establish a definitive diagnosis, and management of various conditions that produce flushing.(AU).
Descritores:DOENCAS DO SISTEMA NERVOSO/compl
DOENCAS DO SISTEMA NERVOSO/diag
DOENCAS DO SISTEMA NERVOSO/fisiopatol
NEOPLASIAS CUTÂNEAS/compl
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/fisiopatol
ACNE ROSACEA/compl
 ACNE ROSACEA/diag
 ACNE ROSACEA/fisiopatol
 NEOPLASIAS/compl
 NEOPLASIAS/fisiopatol
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00323/cme


  4 / 4 HANSEN  
              first record previous record
seleciona
para imprimir
Id:24483
Autor:Gloster HM; Neal K
Título:Skin cancer in skin of color
Skin cancer in skin of color-v.55
Fonte:s.l; s.n; 2006. 19 p. ilus, tab.
Resumo:Skin cancer is less common in persons with skin of color than in light-skinned Caucasians but is often associated with greater morbidity and mortality. Thus, it is crucial that physicians become familiar with skin cancer in persons of color so as to maximize the likelihood of early detection of these tumors. In dark-skinned ethnic groups, squamous cell carcinoma is most common; squamous cell carcinoma and melanoma usually occur on nonsun-exposed sites; and ultraviolet radiation is not an important etiologic factor for skin cancer with the exception of basal cell carcinoma. Races of intermediate pigmentation, such as Hispanics and Asians, share epidemiologic and clinical features of dark-skinned ethnic groups and Caucasians. Skin cancers pose a significant risk in skin of color and clinicians should focus on preventive measures in these groups such as regular skin exams, self-examination, public education, and screening programs. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the epidemiology and unique clinical features of skin cancer in skin of color and be aware of strategies to prevent skin cancer in skin of color.(AU).
Descritores:NEOPLASIAS CUTÂNEAS/quim
NEOPLASIAS CUTÂNEAS/compl
NEOPLASIAS CUTÂNEAS/diag
NEOPLASIAS CUTÂNEAS/genet
NEOPLASIAS CUTÂNEAS/imunol
NEOPLASIAS CUTÂNEAS/prev
NEOPLASIAS CUTÂNEAS/fisiopatol
NEOPLASIAS CUTÂNEAS/reabil
NEOPLASIAS CUTÂNEAS/radioter
NEOPLASIAS CUTÂNEAS/cirurg
NEOPLASIAS CUTÂNEAS/terap
SARCOMA DE KAPOSI/compl
SARCOMA DE KAPOSI/diag
SARCOMA DE KAPOSI/fisiopatol
RAIOS ULTRAVIOLETA/uso diag
 TERAPIA ULTRAVIOLETA/instrum
 TERAPIA ULTRAVIOLETA/métodos
Limites:ESTUDO COMPARATIVO
HUMANO
Localização:BR191.1; 00326/cme



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information